Abstract
Background: Plaque psoriasis has been associated with anxiety, depression, suicidal ideation and various personality traits. However, studies on hypochondriasis, i.e. the belief of serious illness despite having no or only mild symptoms, are currently scarce. Objective: The aim of this study was to assess hypochondriasis and personality traits in psoriasis patients using the Minnesota Multiphasic Personality Inventory-2 (MMPI-2). Methods: We conducted an observational study on patients with plaque psoriasis who underwent MMPI-2 testing. Demographic and clinical data, including comorbidities, alcohol consumption, and smoking, were collected. Results: A total of 136 consecutive psoriatic patients were included. The mean age (±SD) was 53.7 (±13.5), mean PASI (Psoriasis Area Severity Index) was 12.4 (±9.9), and mean disease duration was 23.3 (±15.7) years. Pathologically elevated scores in the Hypochondriasis scale were observed in 27.9% of patients. Furthermore, in a few other MMPI-2 scales (Anxiety, Fears and Negative Treatment Indicators) ≥25% of patients obtained pathologically elevated scores. Conversely, the scales that had the highest proportion of low scorers were Ego Strength and Dominance. At regression analysis, higher psoriasis severity and female gender were associated with higher scores in the Hypochondriasis scale (p = 0.03 and 0.001). Finally, 72.8% reported any alcohol consumption and 8.1% heavy alcohol consumption. Conclusion: About one third of patients with psoriasis have high scores in the MMPI-2 hypochondriasis evaluation scale. Poor individual coping resources also appeared to be distinctive psychological features in a significant proportion of psoriatic patients.
References
1.
Fleming
P
, Bai
JW
, Pratt
M
, Sibbald
C
, Lynde
C
, Gulliver
WP
. The prevalence of anxiety in patients with psoriasis: a systematic review of observational studies and clinical trials
. J Eur Acad Dermatol Venereol
. 2017 May
;31
(5
):798
–807
. .2.
Dalgard
FJ
, Gieler
U
, Tomas-Aragones
L
, Lien
L
, Poot
F
, Jemec
GBE
, The psychological burden of skin diseases: a cross-sectional multicenter study among dermatological out-patients in 13 European countries
. J Invest Dermatol
. 2015 Apr
;135
(4
):984
–91
. .3.
Cohen
BE
, Martires
KJ
, Ho
RS
. Psoriasis and the Risk of Depression in the US Population: National Health and Nutrition Examination Survey 2009-2012
. JAMA Dermatol
. 2016 Jan
;152
(1
):73
–9
. .4.
Kurd
SK
, Troxel
AB
, Crits-Christoph
P
, Gelfand
JM
. The risk of depression, anxiety, and suicidality in patients with psoriasis: a population-based cohort study
. Arch Dermatol
. 2010 Aug
;146
(8
):891
–5
. .5.
Koo
J
, Marangell
LB
, Nakamura
M
, Armstrong
A
, Jeon
C
, Bhutani
T
, Depression and suicidality in psoriasis: review of the literature including the cytokine theory of depression
. J Eur Acad Dermatol Venereol
. 2017 Dec
;31
(12
):1999
–2009
. .6.
Ferreira
BI
, Abreu
JL
, Reis
JP
, Figueiredo
AM
. Psoriasis and associated psychiatric disorders: a systematic review on etiopathogenesis and clinical correlation
. J Clin Aesthet Dermatol
. 2016 Jun
;9
(6
):36
–43
.7.
Miller
AH
, Raison
CL
. The role of inflammation in depression: from evolutionary imperative to modern treatment target
. Nat Rev Immunol
. 2016 Jan
;16
(1
):22
–34
. .8.
Raison
CL
, Capuron
L
, Miller
AH
. Cytokines sing the blues: inflammation and the pathogenesis of depression
. Trends Immunol
. 2006 Jan
;27
(1
):24
–31
. .9.
Dowlati
Y
, Herrmann
N
, Swardfager
W
, Liu
H
, Sham
L
, Reim
EK
, A meta-analysis of cytokines in major depression
. Biol Psychiatry
. 2010 Mar 1
;67
(5
):446
–57
. .10.
Brenaut
E
, Horreau
C
, Pouplard
C
, Barnetche
T
, Paul
C
, Richard
MA
, Alcohol consumption and psoriasis: a systematic literature review
. J Eur Acad Dermatol Venereol
. 2013 Aug
;27 Suppl 3
(Suppl 3
):30
–5
. .11.
Adamzik
K
, McAleer
MA
, Kirby
B
. Alcohol and psoriasis: sobering thoughts
. Clin Exp Dermatol
. 2013 Dec
;38
(8
):819
–22
. .12.
Basińska
MA
, Woźniewicz
A
. The relation between type D personality and the clinical condition of patients suffering from psoriasis
. Postepy Dermatol Alergol
. 2013 Dec
;30
(6
):381
–7
. .13.
Lim
DS
, Bewley
A
, Oon
HH
. Psychological profile of patients with psoriasis
. Ann Acad Med Singap
. 2018 Dec
;47
(12
):516
–22
.14.
Molina-Leyva
A
, Caparros-delMoral
I
, Ruiz-Carrascosa
JC
, Naranjo-Sintes
R
, Jimenez-Moleon
JJ
. Elevated prevalence of Type D (distressed) personality in moderate to severe psoriasis is associated with mood status and quality of life impairment: a comparative pilot study
. J Eur Acad Dermatol Venereol
. 2015 Sep
;29
(9
):1710
–7
. .15.
Dehghani
F
, Dehghani
F
, Kafaie
P
, Taghizadeh
MR
. Alexithymia in different dermatologic patients
. Asian J Psychiatr
. 2017 Feb
;25
:42
–5
. .16.
Kotrulja
L
, Tadinac
M
, Joki-Begi
NA
, Gregurek
R
. A multivariate analysis of clinical severity, psychological distress and psychopathological traits in psoriatic patients
. Acta Derm Venereol
. 2010 May
;90
(3
):251
–6
. .17.
American Psychiatric Association
.Diagnostic and statistical manual of mental disorders
. Washington, DC
: DSM-IV-TR
; 2000
.18.
Taylor
W
, Gladman
D
, Helliwell
P
, Marchesoni
A
, Mease
P
, Mielants
H
. Classification criteria for psoriatic arthritis: development of new criteria from a large international study
. Arthritis Rheum
. 2006 Aug
;54
(8
):2665
–73
. .19.
Schiele
BC
, Baker
AB
, Hathaway
SR
. The Minnesota multiphasic personality inventory
. Lancet
. 1943
;63
:292
–7
.20.
Giunti O.S. Psychometrics. Il test MMPI-2 dopo oltre 20 anni: la nuova standardizzazione italiana. Available from: https://www.giuntios.it/media/9848083.mmpi-2-nuove-norme-impaginato.pdf. Accessed 11th April 2021.
21.
Butcher
JN
, Dahlstrom
WG
, Graham
JR
, Tellegen
A
. MMPI-2 manual for administration and scoring
. Minneapolis, MN
: University of Minnesota Press
; 1989
.22.
23.
Sinnett
ER
, Holen
MC
, Albott
WL
. Profile validity standards for MMPI and MMPI-2 F scales
. Psychol Rep
. 1999 Feb
;84
(1
):288
–90
. .24.
Graham
JR
. MMPI-2: Assessing Personality and Psychopathology
. 5th ed. New York
: Oxford University Press
; 2012
.25.
Alfani
S
, Antinone
V
, Mozzetta
A
, Di Pietro
C
, Mazzanti
C
, Stella
P
, Psychological status of patients with alopecia areata
. Acta Derm Venereol
. 2012 May
;92
(3
):304
–6
. .26.
Weck
F
, Richtberg
S
, Neng
J
. Epidemiology of hypochondriasis and health anxiety: comparison of different diagnostic criteria
. Curr Psychiatry Rev
. 2014
;10
(1
):14–23
. .27.
Potekaev
NN
, Khamaganova
IV
, Malyarenko
EN
, Minin
DA
, Vorobiev
AB
, Novoseltsev
MV
, Acta Derm Venereol
. 2016
;Suppl 217
:118
.28.
Hrehorów
E
, Salomon
J
, Matusiak
L
, Reich
A
, Szepietowski
JC
. Patients with psoriasis feel stigmatized
. Acta Derm Venereol
. 2012 Jan
;92
(1
):67
–72
. .29.
von Spreckelsen
R
, Sommer
R
, Mrowietz
U
. Stigmatization experience of people with psoriasis. A qualitative analysis from the point of view of affected persons, relatives and health care professionals (HCPs)
. Acta Derm Venereol
. 2019
;99
:750
.30.
Zimmermann
CF
, Revenson
TA
. Skin disease implications for self-image development in adolescence and young adulthood
. Acta Derm Venereol
. 2019
;99
:725
–6
.31.
Nazik
H
, Nazik
S
, Gul
FC
. Body image, self-esteem, and quality of life in patients with psoriasis
. Indian Dermatol Online J
. 2017 Sep-Oct
;8
(5
):343
–6
. .32.
Słomian
A
, Łakuta
P
, Bergler-Czop
B
, Brzezińska-Wcisło
L
. Self-esteem is related to anxiety in psoriasis patients: A case control study
. J Psychosom Res
. 2018 Nov
;114
:45
–9
. .33.
Magin
P
, Adams
J
, Heading
G
, Pond
D
, Smith
W
. The psychological sequelae of psoriasis: results of a qualitative study
. Psychol Health Med
. 2009 Mar
;14
(2
):150
–61
. .34.
Remroed
C
, Sjostrom
K
. Personality traits in patients with psoriasis
. Acta Derm Venereol
. 2016
;Suppl 217
:10
–1
.35.
Saeki
H
, Imafuku
S
, Abe
M
, Shintani
Y
, Onozuka
D
, Hagihara
A
, Poor adherence to medication as assessed by the Morisky Medication Adherence Scale-8 and low satisfaction with treatment in 237 psoriasis patients
. J Dermatol
. 2015 Apr
;42
(4
):367
–72
. .36.
Wang
W
, Qiu
Y
, Zhao
F
, Zhang
F
. Poor medication adherence in patients with psoriasis and a successful intervention
. J Dermatolog Treat
. 2019 Sep
;30
(6
):525
–8
. .37.
Kuehl
B
, Shear
NH
. The evolution of topical formulations in psoriasis
. Skin Therapy Lett
. 2018 Jul
;23
(4
):5
–9
.38.
Alpsoy
E
, Polat
M
, FettahlıoGlu-Karaman
B
, Karadag
AS
, Kartal-Durmazlar
P
, YalCın
B
, Internalized stigma in psoriasis: A multicenter study
. J Dermatol
. 2017 Aug
;44
(8
):885
–91
. .39.
Fortune
DG
, Richards
HL
, Kirby
B
, Bowcock
S
, Main
CJ
, Griffiths
CE
. A cognitive-behavioural symptom management programme as an adjunct in psoriasis therapy
. Br J Dermatol
. 2002 Mar
;146
(3
):458
–65
. .40.
Chen
Y
, Xin
T
, Cheng
AS
. Evaluating the effectiveness of psychological and/or educational interventions in psoriasis: a narrative review
. J Dermatol
. 2014 Sep
;41
(9
):775
–8
. .41.
Kabat-Zinn
J
, Wheeler
E
, Light
T
, Skillings
A
, Scharf
MJ
, Cropley
TG
, Influence of a mindfulness meditation-based stress reduction intervention on rates of skin clearing in patients with moderate to severe psoriasis undergoing phototherapy (UVB) and photochemotherapy (PUVA)
. Psychosom Med
. 1998 Sep-Oct
;60
(5
):625
–32
. .42.
Fordham
B
, Griffiths
CE
, Bundy
C
. A pilot study examining mindfulness-based cognitive therapy in psoriasis
. Psychol Health Med
. 2015
;20
(1
):121
–7
. .43.
Fordham
BA
, Nelson
P
, Griffiths
CE
, Bundy
C
. The acceptability and usefulness of mindfulness-based cognitive therapy for people living with psoriasis: a qualitative study
. Br J Dermatol
. 2015 Mar
;172
(3
):823
–5
. .44.
Bundy
C
, Pinder
B
, Bucci
S
, Reeves
D
, Griffiths
CE
, Tarrier
N
. A novel, web-based, psychological intervention for people with psoriasis: the electronic Targeted Intervention for Psoriasis (eTIPs) study
. Br J Dermatol
. 2013 Aug
;169
(2
):329
–36
. .45.
Noyes
R
, Jr, Longley
SL
, Langbehn
DR
, Stuart
SP
, Kukoyi
OA
. Hypochondriacal symptoms associated with a less therapeutic physician-patient relationship
. Psychiatry
. 2010 Spring
;73
(1
):57
–69
. .46.
Epicentro. Il portale dell'epidemiologia per la sanità pubblica a cura dell'Istituto superiore di sanità. Available from: https://www.epicentro.iss.it/passi/dati/alcol#dati. Accessed on 11th April 2021.
47.
Al-Jefri
K
, Newbury-Birch
D
, Muirhead
CR
, Gilvarry
E
, Araújo-Soares
V
, Reynolds
NJ
, High prevalence of alcohol use disorders in patients with inflammatory skin diseases
. Br J Dermatol
. 2017 Sep
;177
(3
):837
–44
. .48.
Wolf
R
, Wolf
D
, Ruocco
V
. Alcohol intake and psoriasis
. Clin Dermatol
. 1999 Jul-Aug
;17
(4
):423
–30
. .49.
Higgins
EM
, du Vivier
AW
. Cutaneous disease and alcohol misuse
. Br Med Bull
. 1994 Jan
;50
(1
):85
–98
. .50.
Kirby
B
, Richards
HL
, Mason
DL
, Fortune
DG
, Main
CJ
, Griffiths
CE
. Alcohol consumption and psychological distress in patients with psoriasis
. Br J Dermatol
. 2008 Jan
;158
(1
):138
–40
. .51.
Gupta
MA
, Schork
NJ
, Gupta
AK
, Ellis
CN
. Alcohol intake and treatment responsiveness of psoriasis: a prospective study
. J Am Acad Dermatol
. 1993 May
;28
(5 Pt 1
):730
–2
. .© 2021 S. Karger AG, Basel
2021
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
